Immuron (IMRN) Cash from Operations (2016 - 2024)
Immuron (IMRN) recorded quarterly Cash from Operations of 2611499.82 in Q4 2024, down 100.19% quarter-over-quarter from 1304478.16 in Q4 2023, and down 100.19% on a YoY basis from 1339354581.49 in Q1 2024.
Immuron (IMRN) Cash from Operations (2016 - 2024) Analysis & Trends
Immuron's Cash from Operations history runs 9 years deep, the most recent figure standing at 2611499.82 for Q4 2024.
- In Q4 2024, Cash from Operations fell 100.19% year-over-year to 2611499.82; the TTM figure through Dec 2024 stood at 6891328.42 (up 1.4% YoY), while the FY2025 annual figure was 6136949.0, down 4.37% from the prior year.
- Cash from Operations was 2611499.82 for Q4 2024 at Immuron, down from 1304478.16 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 992017.0 in Q4 2022 to a low of 2709405.0 in Q4 2020.
- Historically, Cash from Operations has averaged 1920146.68 across 5 years, with a median of 1983333.44 in 2021.
- The sharpest annual moves came in 2022 and 2024: Cash from Operations soared 49.98% in 2022, then tumbled 100.19% in 2024.
- A 5-year view of Cash from Operations shows it stood at 2709405.0 in 2020, then increased by 26.8% to 1983333.44 in 2021, then jumped by 49.98% to 992017.0 in 2022, then plunged by 31.5% to 1304478.16 in 2023, then sank by 100.19% to 2611499.82 in 2024.
- The last three Cash from Operations figures came in at 2611499.82 (Q4 2024), 1304478.16 (Q4 2023), and 992017.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Immuron | 1.05 Bn | 1.05 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2024 | -2.61 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Dec 31, 2023 | -1.30 Mn |
| Dec 31, 2022 | -992,017.00 |
| Dec 31, 2022 | -992,017.00 |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2021 | -1.98 Mn |
| Dec 31, 2020 | -2.71 Mn |
| Dec 31, 2020 | -2.71 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2019 | -1.56 Mn |
| Dec 31, 2018 | -424,940.00 |
| Dec 31, 2018 | -424,940.00 |
| Dec 31, 2017 | -2.48 Mn |
| Dec 31, 2017 | -2.48 Mn |
| Dec 31, 2016 | 1.67 Mn |
| Dec 31, 2016 | 1.67 Mn |